MedTrace Logo

A Computer-aided (CADx）System in Real-time Characterization of Colorectal Ulcerative Diseases

NCT06208982 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2024-01-17

No results posted yet for this study

Summary

The goal of this observational study is to construct and validate a Computer-aided (CADx）System in Real-time Characterization of Colorectal Ulcrerative Diseases. The main question it aims to answer are to demonstrate whether the newly developed CADx system has a high-level diagnostic accuracy in predicting characterization of colorectal ulcerative diseases.

It is a multi-center, retrospective study. The study retrospectively collected colonoscopy images and videos of colorectal ulcers (including colorectal cancer, Crohn's disease, Ulcerative colitis, Intestinal tuberculosis and ischemic enteritis). A training cohort will be developed from majority of the included cases, followed by a validation cohort with the remaining cases. A CADx system in real-time characterization of colonic ulcer diseases was constructed using artificial intelligence to extract endoscopic features from the training set. Subsequently, the performance of the CADx system was preliminarily tested through the validation set.

Conditions

  • Colorectal Ulcers
  • Computer-aided System

Interventions

DIAGNOSTIC_TEST

Colonoscopy images and videos

A CADx system in real-time characterization of colonic ulcer diseases was constructed using artificial intelligence to extract endoscopic features from the training set. Subsequently, the performance of the CADx system was preliminarily tested through the validation set.

Sponsors & Collaborators

  • Prince of Wales Hospital, Shatin, Hong Kong

    collaborator OTHER

  • ZhuHai Hospital

    collaborator OTHER

  • Wuxi People's Hospital

    collaborator OTHER

  • The Second Affiliated Hospital of the Chinese University of Hong Kong (Shenzhen)

    collaborator UNKNOWN

  • Nanfang Hospital, Southern Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2024-06-30
Completion
2024-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06208982 on ClinicalTrials.gov